AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson’s
At AD/PD 2025, Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early Parkinson’s disease (PD).

What's Your Reaction?






